Kim Raineri
Chief Technology Officer, Aspen Neuroscience
Kim Raineri is listed as Chief Technology Officer, Aspen Neuroscience. Kim is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Kim. Is this you? Claim this profile.
About
Mr. Raineri is the Chief Technology Officer for Aspen Neuroscience, Inc. He is responsible for the Manufacturing, Supply Chain, Process and Analytical Development, Technology Development, and Delivery Device functions of a leading autologous iPSC derived cell therapy company targeting CNS diseases. Prior to his position at Aspen, he was the Chief Manufacturing and Technology Officer for AVROBIO. He has also held various positions of responsibility in Cell and Gene Therapy Contract Manufacturing and Development Organizations (CDMO) as Vice President of Operations for Nikon CeLL innovation, Business Director for Lonza Bioscience Singapore Pte Ltd., and Director of Operations for Lonza Walkersville. Kim has a Master’s of Business Administration from Kennesaw State University and Bachelor’s of Science from the University of Miami.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Session 3: iPSCs – what does the future hold? Part 1 Speaker · 19 January 2027
- Session 4: iPSCs – what does the future hold? Part 2 Speaker · 19 January 2027
Spoke alongside
People who have shared a session with Kim at events on B2DB.
- Dhruv Sareen Founding Director, (IPSC) Core Facility, Cedars-Sinai & Founding Executive Director · Cedars-Sinai Biomanufacturing Center 2 shared sessions
- Craig Beasley Chief Technology Officer · BlueRock Therapeutics 1 shared session
- Eugene Jiaxian Wang Founder & CEO · HELP Therapeutics 1 shared session
- Ignacio Willats Co-Founder & CCO · Mytos 1 shared session
- Jeanne Loring Professor Emeritus · Scripps Research 1 shared session
- Tunde Babalola Senior Vice President, Technical Operations & Quality · Fate Therapeutics 1 shared session